Moderna Stock Trending Down Despite Vaccine Approval | $MRNA Stock Analysis
Despite vaccine approval and beginning of distribution to the American public, Moderna Stock is trending down.
Similar to Pfizer stock that we took a look at last week, we have are seeing these stocks trending down in the market over the last few days despite all the good news that is happening. Now one could say that when there is good news the stock goes down and when there is bad news the stock goes up. Regardless of how you look at it, there is a lot to be said about MRNA stock and we wanted to give it the 8 Pillars look like we with PFE stock to see how it measures up fundamentally.
Moderna ($MRNA) is an American biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA. Moderna's technology platform inserts synthetic nucleoside-modified mRNA into human cells.
--------------------
Join our Patreon! - / everythingmoney
Check out Charles Schwab and Create Your account today! : http://www.schwab.com/public/schwab/n...
--------------------
*WANT BOOKS WE RECOMMEND FOR INVESTING*
The Intelligent Investor: https://amzn.to/3athjmX
One Up On Wall Street: https://amzn.to/2XYJeGf
Beating The Street: https://amzn.to/3ixVXre
--------------------
SUBSCRIBE: https://www.youtube.com/channel/UChBV...
Video editing by Rohan and Sharvari (The Tweaky Tales)
⚠️⚠️⚠️⚠️⚠️Disclaimer⚠️⚠️⚠️⚠️⚠️
Our channel disclaimer can be found here: https://bit.ly/3n0NxuD